Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy
ChemPlusChem · 2026
DOI: 10.1002/cplu.70225 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, 2026. Verfasst von Faith Muthoni Wangui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: Primaquine, Cobalt, Electrochemical Techniques, Oxides. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: College of Health Sciences, University of KwaZulu-Natal, College of Health Sciences.
Abstract (Originalsprache)
Patients’ compliance with primaquine treatment is low due to the long 14‐day duration of primaquine and the toxic side effects, including acute hemolytic anemia. This study aimed to develop a cobalt oxide/nickel cobalt sulfide/poly(1,8‐diaminonaphthalene) (Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN))‐based electrochemical sensor for monitoring primaquine in urine to combat low adherence. The Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) nanocomposite was synthesized using hydrothermal and oxidative polymerization and characterized using high‐resolution transmission electron microscopy (HRTEM), energy‐dispersive X‐ray spectroscopy (EDS), scanning electron microscopy (SEM), and Fourier transform infrared spectroscopy (FTIR). Differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy were used to study the electrochemical properties of the nanocomposite. A 5 μL aliquot of Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) was drop‐casted onto the glassy carbon electrode, and DPV was used to evaluate the electrochemical sensor’s performance. A linear calibration response was established over primaquine’s concentration range of 10–50 µM. The study found a detection limit of 2.51 nM with a linear concentration range of 10–50 µM. Real sample analysis in urine demonstrated recovery ranges of 98.3%–101.1%. This study reports, for the first time, the synthesis of the Co 3 O 4 @NiCo 2 S 4 @poly(1,8‐DAN) ternary nanocomposite and its application for the detection of primaquine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Malachie Monyele Tembo, Rajshekhar Karpoormath
Förderung
- College of Health Sciences, University of KwaZulu-Natal
- College of Health Sciences
Zitieren
APA
Wangui, F. M., Adu, D. K., Alake, J., Tembo, M. M., & Karpoormath, R. (2026). Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy. ChemPlusChem. https://doi.org/10.1002/cplu.70225
Vancouver
Wangui FM, Adu DK, Alake J, Tembo MM, Karpoormath R. Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy. ChemPlusChem. 2026. doi:10.1002/cplu.70225
BibTeX
@article{Wangui2026,
author = {Wangui, Faith Muthoni and Adu, Darko Kwabena and Alake, John and Tembo, Malachie Monyele and Karpoormath, Rajshekhar},
title = {Cobalt Oxide/Nickel Cobalt Sulfide/Poly(1,8‐diaminonaphthalene) Electrochemical Sensor‐Based Therapeutic Monitoring of Primaquine in Urine to Combat Low Treatment Adherence in Vivax Malaria Therapy},
journal = {ChemPlusChem},
year = {2026},
doi = {10.1002/cplu.70225}
}
EUVIMED